Click here to close
Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly.
We suggest using a current version of Chrome,
FireFox, or Safari.
Akazawa,
Differential expression of five N-methyl-D-aspartate receptor subunit mRNAs in the cerebellum of developing and adult rats.
1994, Pubmed
Akazawa,
Differential expression of five N-methyl-D-aspartate receptor subunit mRNAs in the cerebellum of developing and adult rats.
1994,
Pubmed
Allen,
Unexplained early onset epileptic encephalopathy: Exome screening and phenotype expansion.
2016,
Pubmed
Burnashev,
NMDA receptor subunit mutations in neurodevelopmental disorders.
2015,
Pubmed
Carvill,
GRIN2A mutations cause epilepsy-aphasia spectrum disorders.
2013,
Pubmed
Chen,
Functional Evaluation of a De Novo GRIN2A Mutation Identified in a Patient with Profound Global Developmental Delay and Refractory Epilepsy.
2017,
Pubmed
Choi,
Glutamate receptors and the induction of excitotoxic neuronal death.
1994,
Pubmed
Coyle,
NMDA receptor and schizophrenia: a brief history.
2012,
Pubmed
Dalmau,
Clinical experience and laboratory investigations in patients with anti-NMDAR encephalitis.
2011,
Pubmed
Dirnagl,
Pathobiology of ischaemic stroke: an integrated view.
1999,
Pubmed
Dunah,
Subunit composition of N-methyl-D-aspartate receptors in the central nervous system that contain the NR2D subunit.
1998,
Pubmed
Dunah,
Subcellular segregation of distinct heteromeric NMDA glutamate receptors in the striatum.
2003,
Pubmed
Endele,
Mutations in GRIN2A and GRIN2B encoding regulatory subunits of NMDA receptors cause variable neurodevelopmental phenotypes.
2010,
Pubmed
Gao,
A de novo loss-of-function GRIN2A mutation associated with childhood focal epilepsy and acquired epileptic aphasia.
2017,
Pubmed
González-Pérez,
Improving the assessment of the outcome of nonsynonymous SNVs with a consensus deleteriousness score, Condel.
2011,
Pubmed
Lal,
Investigation of GRIN2A in common epilepsy phenotypes.
2015,
Pubmed
Lek,
Analysis of protein-coding genetic variation in 60,706 humans.
2016,
Pubmed
Lemke,
Mutations in GRIN2A cause idiopathic focal epilepsy with rolandic spikes.
2013,
Pubmed
,
Xenbase
Lemke,
Delineating the GRIN1 phenotypic spectrum: A distinct genetic NMDA receptor encephalopathy.
2016,
Pubmed
,
Xenbase
Lesca,
GRIN2A mutations in acquired epileptic aphasia and related childhood focal epilepsies and encephalopathies with speech and language dysfunction.
2013,
Pubmed
Li,
Fast and accurate long-read alignment with Burrows-Wheeler transform.
2010,
Pubmed
Li,
GRIN2D Recurrent De Novo Dominant Mutation Causes a Severe Epileptic Encephalopathy Treatable with NMDA Receptor Channel Blockers.
2016,
Pubmed
Lopez de Armentia,
Development and subunit composition of synaptic NMDA receptors in the amygdala: NR2B synapses in the adult central amygdala.
2003,
Pubmed
Menniti,
Allosteric modulators for the treatment of schizophrenia: targeting glutamatergic networks.
2013,
Pubmed
Monyer,
Developmental and regional expression in the rat brain and functional properties of four NMDA receptors.
1994,
Pubmed
O'Roak,
Exome sequencing in sporadic autism spectrum disorders identifies severe de novo mutations.
2011,
Pubmed
Obrenovitch,
Effects of L-701,324, a high-affinity antagonist at the N-methyl-D-aspartate (NMDA) receptor glycine site, on the rat electroencephalogram.
1997,
Pubmed
Ogden,
Molecular Mechanism of Disease-Associated Mutations in the Pre-M1 Helix of NMDA Receptors and Potential Rescue Pharmacology.
2017,
Pubmed
,
Xenbase
Pierson,
GRIN2A mutation and early-onset epileptic encephalopathy: personalized therapy with memantine.
2014,
Pubmed
,
Xenbase
Platzer,
GRIN2B encephalopathy: novel findings on phenotype, variant clustering, functional consequences and treatment aspects.
2017,
Pubmed
Reutlinger,
Deletions in 16p13 including GRIN2A in patients with intellectual disability, various dysmorphic features, and seizure disorders of the rolandic region.
2010,
Pubmed
Rothman,
Excitotoxicity and the NMDA receptor--still lethal after eight years.
1995,
Pubmed
Salter,
NMDA receptors are expressed in developing oligodendrocyte processes and mediate injury.
2005,
Pubmed
Singh,
De Novo Heterogeneous Mutations in SCN2A and GRIN2A Genes and Seizures With Ictal Vocalizations.
2016,
Pubmed
Soto,
Glutamate receptor mutations in psychiatric and neurodevelopmental disorders.
2014,
Pubmed
Swanger,
Mechanistic Insight into NMDA Receptor Dysregulation by Rare Variants in the GluN2A and GluN2B Agonist Binding Domains.
2016,
Pubmed
Tarabeux,
Rare mutations in N-methyl-D-aspartate glutamate receptors in autism spectrum disorders and schizophrenia.
2011,
Pubmed
Traynelis,
Glutamate receptor ion channels: structure, regulation, and function.
2010,
Pubmed
Traynelis,
Control of voltage-independent zinc inhibition of NMDA receptors by the NR1 subunit.
1998,
Pubmed
,
Xenbase
Turner,
GRIN2A: an aptly named gene for speech dysfunction.
2015,
Pubmed
Venkateswaran,
Whole-exome sequencing in an individual with severe global developmental delay and intractable epilepsy identifies a novel, de novo GRIN2A mutation.
2014,
Pubmed
Yuan,
Functional analysis of a de novo GRIN2A missense mutation associated with early-onset epileptic encephalopathy.
2014,
Pubmed
Yuan,
Ionotropic GABA and Glutamate Receptor Mutations and Human Neurologic Diseases.
2015,
Pubmed
Yurkewicz,
The effect of the selective NMDA receptor antagonist traxoprodil in the treatment of traumatic brain injury.
2005,
Pubmed
de Ligt,
Diagnostic exome sequencing in persons with severe intellectual disability.
2012,
Pubmed
